The team chemically synthesised nearly 300 of the AI-generated genomes and tested them in laboratory conditions, with sixteen of the resulting viruses proving viable.
The companies will combine Evotec’s screening technologies, compound libraries and AI-enabled discovery platform with Odyssey’s expertise in the biology of autoimmune and inflammatory diseases.
The initiative supports Abu Dhabi’s broader strategy to use digital health technologies, real-world evidence and artificial intelligence to advance preventive and personalised healthcare.
Novo Nordisk will also use H1’s technology to support several aspects of clinical research, including trial design, patient enrollment and clinical trial site selection.
The company has launched Invenia Automated Breast Ultrasound (ABUS) Prime and ABUS StreamVue, which target different stages of the breast imaging workflow.
DeepHealth Breast Ultrasound automates several stages of breast ultrasound examinations, including lesion detection, characterisation and reporting.
eyonis LCS is a Software as a Medical Device that uses AI to assist clinicians in detecting and diagnosing lung cancer during screening workflows.
RushData aims to address these bottlenecks by bringing antibody expression, binding analysis and early developability profiling into a standardised workflow.
Moscow opened access to its MosMedAI platform to healthcare institutions across Russia in 2024, following a decree by Russian President Vladimir Putin.
Under the agreement, Sheba physicians will receive early access to new healthcare models before their wider release, while the partnership will also expand research collaboration between the two organizations.